Esnouf RM - Search Results

1

Gene polymorphism in Netherton and common atopic disease.

Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, Wong K, Abecasis GR, Jones EY, Harper JI, Hovnanian A, Cookson WO. Walley AJ, et al. Among authors: esnouf rm. Nat Genet. 2001 Oct;29(2):175-8. doi: 10.1038/ng728. Nat Genet. 2001. PMID: 11544479

2

The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D.

Love CA, Harlos K, Mavaddat N, Davis SJ, Stuart DI, Jones EY, Esnouf RM. Love CA, et al. Among authors: esnouf rm. Nat Struct Biol. 2003 Oct;10(10):843-8. doi: 10.1038/nsb977. Epub 2003 Sep 7. Nat Struct Biol. 2003. PMID: 12958590

3

Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur.

Brown J, Esnouf RM, Jones MA, Linnell J, Harlos K, Hassan AB, Jones EY. Brown J, et al. Among authors: esnouf rm. EMBO J. 2002 Mar 1;21(5):1054-62. doi: 10.1093/emboj/21.5.1054. EMBO J. 2002. PMID: 11867533 Free PMC article.

4

Structure determination of human semaphorin 4D as an example of the use of MAD in non-optimal cases.

Esnouf RM, Love CA, Harlos K, Stuart DI, Jones EY. Esnouf RM, et al. Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):108-15. doi: 10.1107/S0907444905034992. Epub 2005 Dec 14. Acta Crystallogr D Biol Crystallogr. 2006. PMID: 16369100

5

Benefits of automated crystallization plate tracking, imaging, and analysis.

Mayo CJ, Diprose JM, Walter TS, Berry IM, Wilson J, Owens RJ, Jones EY, Harlos K, Stuart DI, Esnouf RM. Mayo CJ, et al. Among authors: esnouf rm. Structure. 2005 Feb;13(2):175-82. doi: 10.1016/j.str.2004.12.010. Structure. 2005. PMID: 15698562 Free article.

6

The sema domain.

Gherardi E, Love CA, Esnouf RM, Jones EY. Gherardi E, et al. Among authors: esnouf rm. Curr Opin Struct Biol. 2004 Dec;14(6):669-78. doi: 10.1016/j.sbi.2004.10.010. Curr Opin Struct Biol. 2004. PMID: 15582390 Review.

7

Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.

Esnouf RM, Ren J, Hopkins AL, Ross CK, Jones EY, Stammers DK, Stuart DI. Esnouf RM, et al. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3984-9. doi: 10.1073/pnas.94.8.3984. Proc Natl Acad Sci U S A. 1997. PMID: 9108091 Free PMC article.

8

A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization.

Walter TS, Diprose JM, Mayo CJ, Siebold C, Pickford MG, Carter L, Sutton GC, Berrow NS, Brown J, Berry IM, Stewart-Jones GB, Grimes JM, Stammers DK, Esnouf RM, Jones EY, Owens RJ, Stuart DI, Harlos K. Walter TS, et al. Among authors: esnouf rm. Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):651-7. doi: 10.1107/S0907444905007808. Epub 2005 May 26. Acta Crystallogr D Biol Crystallogr. 2005. PMID: 15930615 Free PMC article.

9

Computational model for the IGF-II/IGF2r complex that is predictive of mutational and surface plasmon resonance data.

Roche P, Brown J, Denley A, Forbes BE, Wallace JC, Jones EY, Esnouf RM. Roche P, et al. Among authors: esnouf rm. Proteins. 2006 Aug 15;64(3):758-68. doi: 10.1002/prot.21035. Proteins. 2006. PMID: 16741994

10

Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Hopkins AL, Ren J, Esnouf RM, Willcox BE, Jones EY, Ross C, Miyasaka T, Walker RT, Tanaka H, Stammers DK, Stuart DI. Hopkins AL, et al. Among authors: esnouf rm. J Med Chem. 1996 Apr 12;39(8):1589-600. doi: 10.1021/jm960056x. J Med Chem. 1996. PMID: 8648598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page